EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits

Asunción Bustos-Sellers, Almudena Montalvo-Pérez, Araceli Boraita, Gonzalo Saco-Ledo, Lidia B Alejo, David Barranco-Gil, Pedro L Valenzuela, Nerea López-Maldonado, Roser Ferrer-Costa, Javier Esparcia-Estrela, Celia Monteagudo-López, Tomàs Pinós and 3 more

Experimental Physiology · 2026-01 · 111 (1) · 153-166

DOI: 10.1113/ep092644 ↗

At a glance

Journal article in Experimental Physiology, published online on 2025-05-31. Written by Asunción Bustos-Sellers and 14 co-authors. Institution: Department of Sport and Computer Science, Section of Physical Education and Sports, Faculty of Sport, Universidad Pablo de Olavide, Sevilla, Spain. Major MEDLINE topics: Exercise Therapy, Glycogen Storage Disease Type III, Exercise. Cited 3 times so far (Crossref); 78 references. The full text is freely available (open access, CC BY 4.0). Funded by: Spanish Ministry of Economy and Competitiveness and Fondos Feder.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Glycogen storage disease III (GSD‐III) is caused by an inherited deficiency of the glycogen debranching enzyme. Affecting the liver, muscle and heart, GSD‐IIIa is the most common GSD‐III subtype. We evaluated the feasibility and safety of a physical exercise intervention in patients with GSD‐IIIa and its effects at the multisystem level. Nine patients (four female; five children and four adults; 60% of all diagnosed Spanish patients) participated in a 12 week home‐based, remotely supervised programme combining moderate‐intensity endurance and resistance exercises. Training tolerance/adaptation (fatigue severity scale, wellbeing questionnaire) and safety were assessed throughout the intervention period. The following outcomes were determined at baseline and postintervention: Health‐related quality of life; muscle, liver, kidney and cardiac damage/function biomarkers; dual X‐ray absorptiometry‐determined fat/muscle/bone mass; echocardiography‐determined cardiac dimensions and left ventricular global longitudinal strain; endurance capacity indicators during cardiopulmonary exercise testing; and muscle strength. The patients completed a median of 88% (interquartile range, 87%–100%) of the prescribed sessions. The intervention was safe and well tolerated, with no changes in wellbeing over time and with a decrease in perceived fatigue severity during the intervention ( p = 0.002). Barring alanine aminotransferase, there were no changes in blood biomarkers, and the following significant effects were found at postintervention: Decrease in visceral adipose tissue ( p = 0.038); healthier cardiac geometry [from concentric to normal remodelling, with decreases in relative ( p = 0.015) and posterior ( p = 0.042) wall thickness]; and increases in peak oxygen uptake ( p = 0.033), peak power output ( p = 0.017) and knee‐extension isometric strength ( p = 0.012). Although more research is needed, the present findings suggest that exercise should be considered in GSD‐IIIa management.

Subjects

MeSH terms (MEDLINE)

Exercise TherapyGlycogen Storage Disease Type IIIExerciseHumansFemaleMaleAdultChildFeasibility StudiesQuality of LifeMiddle AgedMuscle StrengthAdolescentYoung AdultMuscle, SkeletalResistance Training

Author keywords

aerobic capacityechocardiographglycogenosismuscle strengthresistance training

Authors and institutions

  • Department of Sport and Computer Science, Section of Physical Education and Sports, Faculty of Sport, Universidad Pablo de Olavide, Sevilla, Spain.
  • Department of Real Madrid Graduate School, Faculty of Medicine, Health and Sports, Universidad Europea de Madrid, Madrid, Spain.
  • Department of Sports Sciences, Faculty of Medicine, Health and Sports, Universidad Europea de Madrid, Madrid, Spain.
  • Research Institute of Hospital '12 de Octubre' ('imas12'), Madrid, Spain.
  • Health Center CAP Fundación Asistencial Mútua Terrasa, Barcelona, Spain.
  • Spanish Association of Patients With Glycogenosis (AEEG), Barcelona, Spain.

ORCID profiles: Alejandro Lucia, Alfredo Santalla

Funding

  • Spanish Ministry of Economy and Competitiveness and Fondos Feder

Cite

APA

Bustos-Sellers, A., Montalvo-Pérez, A., Boraita, A., Saco-Ledo, G., Alejo, L. B., Barranco-Gil, D., Valenzuela, P. L., López-Maldonado, N., Ferrer-Costa, R., Esparcia-Estrela, J., Monteagudo-López, C., Pinós, T., Santos-Lozano, A., Lucia, A., & Santalla, A. (2026). Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits. Experimental Physiology, 111(1), 153-166. https://doi.org/10.1113/ep092644

Vancouver

Bustos-Sellers A, Montalvo-Pérez A, Boraita A, Saco-Ledo G, Alejo LB, Barranco-Gil D, et al. Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits. Experimental Physiology. 2026;111(1):153-166. doi:10.1113/ep092644

BibTeX
@article{BustosSellers2026,
  author = {Bustos-Sellers, Asunción and Montalvo-Pérez, Almudena and Boraita, Araceli and Saco-Ledo, Gonzalo and Alejo, Lidia B and Barranco-Gil, David and Valenzuela, Pedro L and López-Maldonado, Nerea and Ferrer-Costa, Roser and Esparcia-Estrela, Javier and Monteagudo-López, Celia and Pinós, Tomàs and Santos-Lozano, Alejando and Lucia, Alejandro and Santalla, Alfredo},
  title = {Physical exercise intervention in glycogen storage disease IIIa: Feasibility and multisystem benefits},
  journal = {Experimental Physiology},
  year = {2026},
  volume = {111},
  number = {1},
  pages = {153--166},
  doi = {10.1113/ep092644}
}
Start for free →